05/14/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
05/13/2024
4:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
05/13/2024
3:02 PM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
8:54 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/30/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/18/2024
3:17 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
|
03/26/2024
7:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:22 PM | Floyd Eric (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:22 PM | Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Sendrow Jerrold (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Dubin Michael F (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:24 PM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Jambulingam Thani (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:26 PM | Singh Vanila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
9:11 AM | SABBY MANAGEMENT, LLC (Filed by)
Virpax Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
7:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
7:58 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
8:08 AM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
12/07/2023
7:50 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/17/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
6:15 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
3:51 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
2:03 PM | Virpax Pharmaceuticals (Filer)
| Form NT 10-Q | |
10/11/2023
3:10 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
8:51 AM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
8:28 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
4:00 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4/A | |
08/16/2023
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:05 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023
7:14 AM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
06/21/2023
3:16 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:17 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/21/2023
3:18 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Tesla Indicator Is Bullish (Ad) If you ever thought you’re too late to see significant returns from Tesla stock…
Please read this short email.
Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla.
It’s all thanks to one unique trade setup that’s specific to this legendary stock.
It’s called the Perfect Tesla Trade.
And it couldn’t be more straightforward… >> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo |
